CEACAM5 and neoplasm: Conventional surveillance with cross-sectional computed tomography (CT) ± carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) misses sub-clinical disease, often attributed to imaging requiring a macroscopic tumor volume and serum markers lacking sensitivity [46,47].